Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology Brothers
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Clinical Consult

Clinical Consult provides expert commentary and insights on designated therapeutic topics.


prostate cancer

Treatment Options in Metastatic Castration-Sensitive Prostate Cancer

December 22nd 2021

Management of Chemotherapy-Ineligible AML: Beyond HMA Monotherapy

Management of Chemotherapy-Ineligible AML: Beyond HMA Monotherapy

August 3rd 2021

Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer

Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer

May 19th 2021

Relapsed/Refractory Multiple Myeloma: Targeted Therapy and BCMA

Relapsed/Refractory Multiple Myeloma: Targeted Therapy and BCMA

May 3rd 2021

Ovarian Cancer: Frontline Therapy

Ovarian Cancer: Frontline Therapy

April 1st 2021

Anthony Lucci, MD

Impact of COVID-19 on the Management of Early-Stage Breast Cancer

February 9th 2021

Using PARP Inhibitors in Frontline Maintenance Therapy of Ovarian Cancer

Using PARP Inhibitors in Frontline Maintenance Therapy of Ovarian Cancer

January 20th 2021

Update on the Treatment of Heavily Pretreated, Relapsed Refractory Multiple Myeloma

Update on the Treatment of Heavily Pretreated, Relapsed Refractory Multiple Myeloma

October 27th 2020

multiple myeloma

Multiple Myeloma: Targeting BCMA in the Heavily Pretreated Population

October 9th 2020

Assessing the Impact of TAILORx on Breast Cancer Management

Assessing the Impact of TAILORx on Breast Cancer Management

June 16th 2020
Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.